OSTX
OS Therapies Incorporated Common Stock
वास्तविक समय मूल्य
मूल्य चार्ट
मुख्य मीट्रिक्स
बाजार मीट्रिक्स
खुलना
$1.840
उच्च
$1.840
कम
$1.840
मात्रा
0.08M
कंपनी के मौलिक सिद्धांत
ट्रेडिंग आँकड़े
संबंधित समाचार
OS Therapies Partners with EVERSANA for the U.S. Commercialization of OST-HER2 in Recurrent, Fully Resected, Pediatric Lung Metastatic Osteosarcoma
OS Therapies Inc. (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology...
D. Boral Capital Maintains Buy on OS Therapies, Maintains $20 Price Target
D. Boral Capital analyst Jason Kolbert maintains OS Therapies with a Buy and maintains $20 price target.
OS Therapies Submits Request for Regenerative Medicine Advanced Therapy (RMAT) Designation to U.S. FDA for OST-HER2 in the Prevention of Metastases in Recurrent, Fully-Resected, Lung Metastatic Pediatric Osteosarcoma
If awarded, OST-HER2 would become the first listeria investigational medicinal product to be awarded the RMAT designation RMAT designation reduces BLA application review time and permits augmented interactions with
संबंधित स्टॉक
BCTXW
BriaCell Therapeutics Corp. Warrant
EOG
EOG Resources
XCUR
Exicure Inc.
BQ
Boqii Holding Limited American Depositary Shares representing Ordinary Shares
GENE
Genetic Technologies Ltd ADS
अपडेट रहें
मूल्य अलर्ट सेट करें, AI विश्लेषण अपडेट और वास्तविक समय बाजार समाचार प्राप्त करें।